National team develops AI virtual cells, 'Baiyao Technology' completes new round of tens of millions of yuan financing | 36Kr first release
Baiyao Technology, an AI virtual cell platform company, has secured tens of millions of yuan in a new funding round led by China Guo Xin Fund. The company utilizes AI to analyze and predict cellular behavior, aiming to revolutionize drug discovery and development by shifting from molecular-level to cell-level modeling. This funding will support the advancement of their AI algorithms, data platform, and industrial applications, positioning AIVC as a foundational infrastructure for life sciences. AI
IMPACT Accelerates AI adoption in drug discovery by enabling cell-level simulation and prediction, potentially reducing R&D costs and timelines.